Literature DB >> 26016647

Rating scales measuring the severity of psychotic depression.

S D Østergaard1,2, A J Rothschild3, A J Flint4,5, B H Mulsant5,6,7, E M Whyte7, A K Leadholm8, P Bech9, B S Meyers10.   

Abstract

OBJECTIVE: Unipolar psychotic depression (PD) is a severe and debilitating syndrome, which requires intensive monitoring. The objective of this study was to provide an overview of the rating scales used to assess illness severity in PD.
METHOD: Selective review of publications reporting results on non-self-rated, symptom-based rating scales utilized to measure symptom severity in PD. The clinical and psychometric validity of the identified rating scales was reviewed.
RESULTS: A total of 14 rating scales meeting the predefined criteria were included in the review. These scales grouped into the following categories: (i) rating scales predominantly covering depressive symptoms, (ii) rating scales predominantly covering psychotic symptoms, (iii) rating scales covering delusions, and (iv) rating scales covering PD. For the vast majority of the scales, the clinical and psychometric validity had not been tested empirically. The only exception from this general tendency was the 11-item Psychotic Depression Assessment Scale (PDAS), which was developed specifically to assess the severity of PD.
CONCLUSION: In PD, the PDAS represents the only empirically derived rating scale for the measurement of overall severity of illness. The PDAS should be considered in future studies of PD and in clinical practice.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  affective disorders; depression; psychometrics; psychoses

Mesh:

Year:  2015        PMID: 26016647      PMCID: PMC4604003          DOI: 10.1111/acps.12449

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  77 in total

1.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

2.  A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.

Authors:  M M Singh; S R Kay
Journal:  Psychopharmacologia       Date:  1975-08-21

3.  Bipolar versus unipolar psychotic outpatient depression.

Authors:  F Benazzi
Journal:  J Affect Disord       Date:  1999-09       Impact factor: 4.839

4.  Missed diagnosis of psychotic depression at 4 academic medical centers.

Authors:  Anthony J Rothschild; Jesse Winer; Alastair J Flint; Benoit H Mulsant; Ellen M Whyte; Moonseong Heo; Susan Fratoni; Michelle Gabriele; Sonja Kasapinovic; Barnett S Meyers
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

5.  Response of psychotic depression subtypes to pharmacotherapy.

Authors:  R F Anton; E A Burch
Journal:  J Affect Disord       Date:  1993-06       Impact factor: 4.839

6.  The Modified Hamilton Rating Scale for Depression: reliability and validity.

Authors:  I W Miller; S Bishop; W H Norman; H Maddever
Journal:  Psychiatry Res       Date:  1985-02       Impact factor: 3.222

7.  Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study.

Authors:  Mario Maj; Raffaele Pirozzi; Lorenza Magliano; Andrea Fiorillo; Luca Bartoli
Journal:  J Clin Psychiatry       Date:  2007-09       Impact factor: 4.384

8.  A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD).

Authors:  Barnett S Meyers; Alastair J Flint; Anthony J Rothschild; Benoit H Mulsant; Ellen M Whyte; Catherine Peasley-Miklus; Eros Papademetriou; Andrew C Leon; Moonseong Heo
Journal:  Arch Gen Psychiatry       Date:  2009-08

9.  Is the Psychotic Depression Assessment Scale a useful diagnostic tool? The CRESCEND study.

Authors:  Seon-Cheol Park; Joonho Choi; Jae-Min Kim; Tae-Youn Jun; Min-Soo Lee; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  J Affect Disord       Date:  2014-05-11       Impact factor: 4.839

10.  Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

Authors:  Heike E Künzel; Nibal Ackl; Martin Hatzinger; Katja Held; Edith Holsboer-Trachsler; Marcus Ising; Wolfgang Kaschka; Siegfried Kasper; Anastasios Konstantinidis; Annette Sonntag; Manfred Uhr; Alexander Yassouridis; Florian Holsboer; Axel Steiger
Journal:  J Psychiatr Res       Date:  2008-11-26       Impact factor: 4.791

View more
  4 in total

1.  Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).

Authors:  Søren D Østergaard; Anthony J Rothschild; Alastair J Flint; Benoit H Mulsant; Ellen M Whyte; Tom Vermeulen; Per Bech; Barnett S Meyers
Journal:  J Affect Disord       Date:  2015-10-22       Impact factor: 4.839

2.  Clinical Validation of the Psychotic Depression Assessment Scale, Hamilton Depression Rating Scale-6, and Brief Psychiatric Rating Scale-5: Results from the Clinical Research Center for Depression Study.

Authors:  Seon-Cheol Park; Eun Young Jang; Jae-Min Kim; Tae-Youn Jun; Min-Soo Lee; Jung-Bum Kim; Hyeon-Woo Yim; Yong Chon Park
Journal:  Psychiatry Investig       Date:  2017-09-11       Impact factor: 2.505

3.  Diagnostic Issues of Depressive Disorders from Kraepelinian Dualism to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Authors:  Seon-Cheol Park; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

4.  Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration.

Authors:  Akihiro Takamiya; Annemiek Dols; Louise Emsell; Christopher Abbott; Antoine Yrondi; Carles Soriano Mas; Martin Balslev Jorgensen; Pia Nordanskog; Didi Rhebergen; Eric van Exel; Mardien L Oudega; Filip Bouckaert; Mathieu Vandenbulcke; Pascal Sienaert; Patrice Péran; Marta Cano; Narcis Cardoner; Anders Jorgensen; Olaf B Paulson; Paul Hamilton; Robin Kampe; Willem Bruin; Hauke Bartsch; Olga Therese Ousdal; Ute Kessler; Guido van Wingen; Leif Oltedal; Taishiro Kishimoto
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 9.306

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.